|
|
Cleveland Clinic 25th Valve Disease, Structural Interventions & Diastology Summit (Online & USB Flash Drive)
Cleveland Clinic celebrates its silver anniversary with the 25th Valve Disease, Structural Interventions and Diastology Summit. This activity provides a comprehensive educational experience for all who diagnose and treat valve disease. A renowned faculty focuses on the mitral, aortic and tricuspid valves, with newest techniques and strategies for imaging and intervention. Worth up to 15 AMA PRA Category I Credits™, this enduring material meets Echo Lab CME requirements. Additionally, phys... |
|
|
19th Annual Primary Care Spring Conference Session 1
Escape to the sun-drenched shores of Palm Coast, Florida, this spring for the 19th Annual Primary Care Spring Conference, hosted at the luxurious Hammock Beach Resort. Held in two sessions, this conference offers primary care clinicians a unique opportunity to enhance their medical knowledge while basking in the warm coastal ambiance. Discover cutting-edge clinical insights amidst the resort's stunning ocean views and indulge in world-class amenities, including a sprawling water park, cha... |
|
|
19th Annual Primary Care Spring Conference Session 2
Escape to the sun-drenched shores of Palm Coast, Florida, this spring for the 19th Annual Primary Care Spring Conference, hosted at the luxurious Hammock Beach Resort. Held in two sessions, this conference offers primary care clinicians a unique opportunity to enhance their medical knowledge while basking in the warm coastal ambiance. Discover cutting-edge clinical insights amidst the resort's stunning ocean views and indulge in world-class amenities, including a sprawling water park, cha... |
|
|
Survival Skills for Today’s Gynecologist® Spring 2025: Advanced Update for All Women’s Healthcare Providers with Practical Tips and Pearls
Welcome to Survival Skills for Today’s Gynecologist Spring 2025 Advanced Update for All Women’s Healthcare Providers delivered by world-class leaders in our field. We are excited to present this comprehensive conference with in-depth lectures. It is packed with high yield practical tips and pearls. All sessions include a summary of clinical tools you can take back and implement in your practice. Ample time is set aside for questions and answers, as well as for you to meet informally with... |
|
|
10th Annual Diabetes, Obesity & Metabolic Disease Conference
Presented by Continuing Education Company for over 30 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This year, CEC is pleased to host the 10th Annual Diabetes, Obesity, & Metabolic Disease Conference to be held in San Diego, California at the Westin San Diego Gaslamp Quarter on April 25-27, 2025.
Program Objectives
As a result of this conference, participants will be able to:
Diagnose and identify ... |
|
|
Pre-Hospital Ultrasound - Blended Course
Pre-hospital ultrasound can be a valuable tool to rapidly diagnose a variety of conditions associated with trauma and/or critically ill patients. Pre-Hospital focused evaluation of the heart, lungs, and abdomen can provide a rapid and safe method to improve the time to diagnose and/or treat these patients resulting in increased patient safety, satisfaction, and over-all improved patient outcomes in time-sensitive situations.
The Blended Pre-Hospital Ultrasound Training Course is specificall... |
|
|
Ultrasound Guided Nerve Blocks in Emergency Medicine Applications - Blended Course
The Ultrasound-Guided Nerve Blocks for Emergency Medicine Blended Course is designed for Emergency Medicine Physicians seeking to integrate ultrasound-guided nerve blocks for pain management or procedural applications into their clinical practice. It is the position of American College of Emergency Physicians (ACEP) that Ultrasound-guided nerve blocks are a core skill which emergency physicians are capable of providing to patients. Ultrasound-guided nerve blocks will soon be a required core co... |
|
|
Trauma and Acute Care Sonography - Blended Course
The Trauma and Acute Care Sonography Blended Training Course is specifically designed for physicians, sonographers and other medical professionals who need trauma and acute care sonography training and provides participants a strong foundation to perform the core ultrasound applications as outlined in the ACEP ultrasound practice guidelines.
Begin with the self-paced online course: Taught by leading emergency medicine ultrasound experts, the online course incorporates comprehensive lectur... |
|
|
Comprehensive Sterile Compounding Certificate Program
May 8th - 10th, 2025
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Physicians and other healthcare professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy to compound sterile preparations.
Participants are instructed in the proper aseptic techniques... |
|
|
Updates on the Evolving Role of Multidisciplinary Care Teams for the Management of Patients with Duchenne Muscular Dystrophy
Target Audience
These educational activities are designed for neurologists, pediatric neurologists, global pharmacists, specialty nurses, genetic counselors, medical geneticists, and other physicians involved in multidisciplinary care teams for DMD management.
Program Overview
This enduring activity focuses on improving the care of patients with Duchenne muscular dystrophy (DMD) with regard to effective diagnosis, referral, and treatment. Additionally, the faculty will aim to present stan... |
|
|
Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults
STATEMENT OF NEED
Acid sphingomyelinase deficiency (ASMD) is a rare, hereditary lysosomal storage disease with multisystemic manifestations, including splenomegaly, hepatomegaly, interstitial lung disease, dyslipidemia, bone marrow and lymph node involvement, and sometimes neurological and peripheral nerve involvement. While the most severe form of ASMD, infantile neurovisceral ASMD, results in death in early childhood, chronic forms of ASMD have more prolonged survival but are associated w... |
|
|
Current Standards and New Directions in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura
STATEMENT OF NEED
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life-threatening thrombotic microangiopathy with a rapid onset and progression and a mortality rate of 10% to 20% with prompt treatment. Onset of aTTP is characterized by severe thrombocytopenia, microangiopathic hemolytic anemia, and a constellation of associated symptoms including hemorrhage, neurologic and renal manifestations, cardiac abnormalities, and mesenteric ischemia (Joly et al, 2017). Survivors of f... |
|
|
Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes
STATEMENT OF NEED
Head and neck cancers represent a heterogeneous group of tumors that originate in the lip/oral cavity, hypopharynx, oropharynx, nasopharynx, and larynx. An estimated 66,470 new cases are diagnosed in the United States annually, and 15,050 people die of the disease (Siegel et al, 2022). Approximately 90% of cases are classified as head and neck squamous cell carcinoma (HNSCC). Treatment of HNSCC is complicated by numerous factors, including differing therapeutic strategies ... |
|
|
Exploring Novel Treatments for Rett Syndrome
STATEMENT OF NEED
Rett syndrome is a rare, debilitating neurodevelopmental disorder almost always associated with a spontaneous mutation in the methyl-CpG-binding protein 2 (MECP2) gene on the X-chromosome. Affected individuals experience loss of purposeful hand skills, abnormalities in gait, loss of spoken language, and stereotypic hand movements, with more severe manifestations including seizures, autistic features, autonomic nervous system dysfunction, breathing abnormalities, sleep dist... |
|
|
10th Annual Clinical Issues in Primary Care Conference
Embark on an extraordinary Hawaiian adventure from May 12-16, 2025, as Continuing Education Company presents the 10th Annual Clinical Issues in Primary Care Conference at the luxurious Fairmont Orchid Resort. Immerse yourself in a tropical CME conference designed for primary care clinicians eager to ride the wave of the latest therapeutic advancements. Nestled amidst the Big Island's beauty, this medical conference is your passport to engaging sessions, practical insights, and evidence-ba... |
|
|
NeuroRehabilitation 2025 - LIVE STREAMING
Comprehensive Neurorehabilitation Update
Cutting-edge strategies, updates, and best practices for state-of-the-art rehabilitation
In this course, which is among the highest-rated Harvard Medical School CME courses, many of the country’s most experienced and committed neurorehabilitation experts will present cutting-edge clinical interventions, the latest findings, practical education, and hands-on methods to further your expertise in guiding your patients with stroke, SCI, TBI, and fun... |
|
|
Highlights from PAS: Rare Disorders - Don't Miss a Treatable Disease
Target Audience
This activity is designed to meet the educational needs of neonatologists, pediatricians, geneticists, family practice, registered nurses, nurse practitioners, physician assistants, genetic counselors, and other HCPs who wish to improve their knowledge and competence in identifying and managing patients with treatable rare disorders through NBS as well as other measures.
Program Overview
This activity will feature clinical cases where newborn screening (NBS) identified a t... |
|
|
Practice-Changing Advances in the Management of Hemophilia
STATEMENT OF NEED
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly, causing affected individuals to experience spontaneous bleeding as well as bleeding after injuries or surgery. The 2 most common types are hemophilia A, caused by low levels of clotting factor VIII; and hemophilia B, caused by low levels of clotting factor IX. The standard treatment for hemophilia involves replacing the missing blood clotting factor by infusing commercially prepared facto... |
|
|
Podcast: Practice-Changing Advances in the Management of Hemophilia
STATEMENT OF NEED
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly, causing affected individuals to experience spontaneous bleeding as well as bleeding after injuries or surgery. The 2 most common types are hemophilia A, caused by low levels of clotting factor VIII; and hemophilia B, caused by low levels of clotting factor IX. The standard treatment for hemophilia involves replacing the missing blood clotting factor by infusing commercially prepared facto... |
|
|
29th Annual Hypertension, Diabetes & Dyslipidemia Conference
Combine medical education and southern charm at the 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference, happening from June 18-20, 2025, at the Hyatt Regency in Savannah, GA. Immerse yourself in a dynamic CME-accredited program, garnering 15.25 credits, designed to address the complexities of diabetes, hypertension, and dyslipidemia. Join healthcare professionals in the historic setting of Savannah, where centuries-old tradition will meet modern clinical insights, creating a tru... |
|
|
New Guidelines and Novel Treatments for PAH: Taking a Forward-Looking Data Dive Into the Pool of Emerging Therapies
Target Audience
This educational activity has been designed to meet the needs of cardiologists, pulmonologists, rheumatologists, and other physicians, including those in primary care and internal medicine, as well as physician assistants, nurse practitioners, and other healthcare providers who may be involved in managing care for patients with pulmonary arterial hypertension (PAH).
Program Overview
Discoveries about the pathogenesis of pulmonary arterial hypertension (PAH) revealed key mo... |
|
|
Distinguishing and Managing Early-Stage Alzheimer’s Disease (AD): Leveraging Interdisciplinary Collaboration for Prompt Identification and Optimal Patient Management
Target Audience
This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members.
Program Overview
This educational activity is designed to provide clinicians who manage patients with Alzheimer’s disease with current information on diagnosis and management, inclu... |
|
|
33rd Annual Primary Care Conference, Session 1
Emmerse yourself in the allure of Kiawah Island, South Carolina, while enhancing your medical expertise at the 33rd Annual Primary Care Conference, CEC's oldest and most popular CME conference. Attend one of two sessions: June 23 - 27 or June 30 - July 4 at the prestigious Kiawah Island Golf Resort. This event allows primary care clinicians to stay updated in rapidly changing therapeutic areas with time to explore Kiawah Island's pristine beaches and lush marshlands, where CEC has be... |
|
|
Myasthenia Gravis Research Highlights: AAN 2024
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in neurology, ophthalmology and family practice. Other members of the care team may also participate.
Program Overview
This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subt... |
|
|
33rd Annual Primary Care Conference, Session 2
Elevate your medical practice at the 33rd Annual Primary Care Conference, CEC's longest-running and most popular CME event, hosted at the prestigious Kiawah Island Golf Resort. Held during two sessions from June 23 - 27 or June 30 - July 4, you have the flexibility to choose the dates that best fit your schedule.
Prepare for enlightening morning sessions led by expert faculty, covering a comprehensive array of topics tailored to the evolving needs of primary care clinicians. Dive into ... |
|
|
Multidisciplinary Team Essentials on CMV Prevention, Surveillance, and Treatment Optimization in the Transplant Setting
The role of the multidisciplinary transplant team has expanded considerably over the past decade to keep pace with advances in the field and to address long-term care of transplant recipients. Despite these advances, breakthrough cytomegalovirus (CMV) infections and development of refractory and resistant CMV infections cause significant complications post-transplant. To lessen patient burden and improve survival outcomes, optimal introduction of anti-CMV drugs, both prophylactically and thera... |
|
|
Cleveland Clinic 27th Annual Diabetes Therapeutics, Technology and Surgery (Online Streaming On Demand)
For over a quarter century, Cleveland Clinic has been at the forefront of continuing education regarding the treatment and management of diabetes. Its world class faculty has designed the 27th Annual Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of strategies and research relevant to this disease and its complications. The goal of this activity is to increase practitioners’ competence and clinical performance in the management of type 1 and type 2 diabetes. A... |
|
|
Identifying Needs and Opportunities to Improve Clinical Outcomes in the Identification, Characterization, and Management of Low-Grade Serous Ovarian Cancer
Target Audience
This activity is designed to meet the educational needs of oncologists, obstetrician/gynecologists, gastroenterologists, and primary care physicians to ensure confidence in the diagnosis, characterization, and management of low-grade serous ovarian cancer, including through enrollment in ongoing clinical trials.
Program Overview
This enduring educational activity will provide insight into evidence-based approaches for clinical and pathological assessment of patients with d... |
|
|
Comprehensive Management of Von Hippel-Lindau Disease: Genetic and Oncological Perspectives
STATEMENT OF NEED
Von Hippel-Lindau disease (VHL) is an autosomal dominant disease in which germline pathogenic variants in the VHL gene predispose individuals to specific types of benign tumors, malignant tumors, and cysts in multiple organs, including clear cell renal cell carcinoma (RCC), renal cysts, central nervous system hemangioblastomas, retinal hemangioblastomas, pancreatic tumors and cysts, endolymphatic sac tumors, and cystadenomas of the epididymis and broad ligament (NIH, 2024). ... |
|
|
9th Annual Internal Medicine in Primary Care Conference
Prepare to embark on an extraordinary voyage of discovery and rejuvenation aboard the Celebrity Edge, where the 9th Annual Internal Medicine in Primary Care Conference awaits amidst the awe-inspiring landscapes of Alaska. From July 25 to August 1, 2025, immerse yourself in the natural splendor of the Inside Passage as you sail through pristine fjords, past towering glaciers, and alongside majestic wildlife. This unique cruise offers a perfect blend of educational enrichment and leisurely explo... |
|
|
How the Patient Experience Should Inform Treatment Selection: Reframing Expectations in EoE for HCPs and Patients
Eosinophilic esophagitis (EoE) has been steadily increasing in prevalence and incidence over the past three decades. Today, EoE has evolved from a rare case-reportable condition to a disease that is commonly encountered in the clinic and endoscopy suite and is a major cause of upper gastrointestinal morbidity and increasing healthcare costs.
Delays in diagnosis persist and management of the disease can be complex. While significant advances in the treatment of EoE have been made, studies s... |
|
|
Beyond Avoidance: IgE-Mediated Food Allergies " Therapeutic Innovations to the Rescue
In the United States, food-induced allergic reactions are the leading cause of anaphylaxis in hospital emergency departments. Among these, immunoglobulin E (IgE)-mediated food allergies are the most common, and they pose significant risks, including cardiac arrest and respiratory failure. Traditionally, treatment options for IgE-mediated food allergies have been primarily limited to food avoidance and anaphylaxis prevention. However, recent years have brought the FDA approval of the first oral... |
|
|
Managing Obesity in Adolescent Patients Your Top 10 Questions Answered
The rate of obesity in children and adolescents is increasing, posing significant physical and mental health challenges through childhood and adolescence and into adulthood. Recently, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been approved for use in patients as young as 12 years, and it is critical that clinicians initiate both lifestyle management and pharmacologic therapies as early as possible. Dr. Fatima Stanford discusses 10 common questions asked about managing obesity ... |
|
|
Nuclear Medicine and Molecular Imaging Update
The Mid East Chapter of the Society of Nuclear Medicine and Molecular Imaging’s historic 50th Annual Conference presents nuclear medicine’s latest trends, advances and procedures. Adapted for the enduring material audience, Nuclear Medicine and Molecular Imaging Update features a dozen faculty members presenting this specialty’s impact on imaging, cardiology, neurology, endocrinology, oncology, rheumatology, pediatrics and much more. Practice enhancements and professional development w... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). Multicancer early detection (MCED) is an emerging form of blood-based testing that utilizes cancer biomarkers in the blood to screen for multiple cancers simultaneously (ACS, 2024). Currently, numerous clinical trials are investiga... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States (ACS, 2024; Pinsky & Berg, 2012; USPSTF, 2024). Multicancer early detection (MCED) is a novel form of blood-based ca... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Recognizing and Confirming Potential ATTR in Your Patients
Target Audience
This activity is designed to meet the educational needs of physicians, allied health practitioners, and students interested in complex cardiovascular and thoracic conditions and those who care for patients with ATTR.
Program Overview
This activity will cover early diagnosis and intervention for transthyretin amyloidosis (ATTR), which is critical, yet does not occur, typically as a consequence of the rarity and heterogeneity of the disease and limited awareness on the part ... |
|
|
ASCVD Clinical Research Updates Targeting Residual Inflammation in Patients with ASCVD and CKD
Emerging evidence and scientific advancements are revealing pathophysiologic mechanisms correlated with systemic inflammation and the development of atherosclerotic cardiovascular disease (ASCVD). Patients with chronic kidney disease (CKD) are at high risk for developing ASCVD. Novel anti-inflammatory therapies are showing efficacy at reducing inflammation and development of ASCVD, and are adding to the treatment options beyond the usual lipid-lowering agents. As new clinical evidence and tar... |
|
|
Geographic Atrophy Secondary to Age-Related Macular Degeneration: Innovative Therapies for Sight Revival
Multimodal imaging is key for the early detection and monitoring of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Optical coherence tomography has recently been recommended by an international consensus to be the primary imaging method for the detection of atrophy in eyes. Once diagnosed, timely therapeutic intervention should be initiated with recently FDA-approved therapies that target components of the complement cascade. When optimally integrated into persona... |
|
|
Podcast: Multidisciplinary Task Force and Position Statement: Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory Multiple Myeloma
STATEMENT OF NEED
With the complex and rapidly evolving treatment landscape of multiple myeloma, it is vital that clinicians not only understand factors for informing selection of current and emerging combination and sequential therapeutic strategies, but also employ interdisciplinary strategies for reducing disparities in relapsed/refractory multiple myeloma care. The development of novel therapeutic options has significantly improved treatment outcomes for patients with relapsed/refractor... |
|
|
Bridging the Health Gaps in Hereditary Angioedema: Demystifying Disparities, Enhancing Quality of Life, and Implementing Effective Prophylactic Solutions
Hereditary angioedema (HAE) is a rare, life-threatening disorder characterized by recurrent, unpredictable episodes of bradykinin-induced swelling. In this presentation, Dr. Marc Reidl, Clinical Director of the US Hereditary Angioedema Association (HAEA) Angioedema Center, reviews multiple underrecognized factors that contribute to health disparities among patients with HAE, including delays in diagnosis and multifaceted differences among racial and ethnic groups, socioeconomic status levels, ... |
|
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the understanding of the racial/ethnic and gender-based disparities among healthcare professionals. This gap... |
|
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the understanding of the racial/ethnic and gender-based disparities among healthcare professionals. This gap... |
|
|
Patient Point of View: PDE4 Inhibitors for the Treatment of Adult Plaque Psoriasis
Psoriasis is a chronic, immune-mediated inflammatory skin disorder that significantly impacts affected individuals’ quality of life. The most common subtype is plaque psoriasis, characterized by erythematous to violaceous plaques covered with scales. Due to the substantial symptom burden of plaque psoriasis and challenges surrounding medication tolerability and adherence, innovative treatment options are needed. Phosphodiesterase-4 (PDE4) inhibitors, which play a key role in the inflammatory... |
|
|
Thyroid Eye Disease: Unmasking and Taming What’s in Disguise
Thyroid eye disease (TED) is a complex autoimmune-mediated inflammatory disorder of the orbit that is associated with a spectrum of signs and symptoms and varying levels of severity. Early diagnosis and initiation of appropriate treatment are imperative for preventing progression to severe disease and potential vision loss. However, diagnosis can be challenging. Traditional treatments for TED, such as steroids, radiotherapy, and surgery, all relieve symptoms but do not alter the course of dise... |
|
|
Cushing’s Syndrome Treatment Research Highlights: ENDO 2024
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in endorcrinology, radiology, neurosurgery, and general practice. Other members of the care team may also participate.
Program Overview
This 30-minute CME program highlights the latest clinical research about Cushing’s syndrome and Cushing’ disease.
Learning Objectives
After participating in the activity, learners should be better able to:
Describe the latest research being ... |
|